(Q46727255)

English

Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS). (English)

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

author name string

Germing U

1

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

Hildebrandt B

2

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

Pfeilstöcker M

3

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

Nösslinger T

4

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

Valent P

5

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

Fonatsch C

6

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

Lübbert M

7

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

Haase D

8

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

Steidl C

9

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

Krieger O

10

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

Stauder R

11

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

Giagounidis AA

12

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

Strupp C

13

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

Kündgen A

14

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

Mueller T

15

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

Haas R

16

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

Gattermann N

17

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

Aul C

18

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

publication date

1 December 2005

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

19

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

2223-2231

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

12

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403963

0 references

Proposals for the classification of the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403963

21 January 2018

Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403963

21 January 2018

Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403963

21 January 2018

Survival analysis and AML development in patients with de novo myelodysplastic syndromes: comparison of six different prognostic scoring systems

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403963

21 January 2018

Two groups of chronic myelomonocytic leukaemia: myelodysplastic and myeloproliferative. Prognostic implications in a series of a single center

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403963

21 January 2018

Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403963

21 January 2018

Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403963

21 January 2018

Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403963

21 January 2018

Myelodysplastic syndromes: a scoring system with prognostic significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403963

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of 18-month survival in patients with primary myelodysplastic syndrome. A regression model and scoring system based on the combination of chromosome findings and the Bournemouth score.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403963

7 January 2021

based on heuristic

inferred from DOI database lookup

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403963

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk assessment in chronic myelomonocytic leukemia (CMML).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403963

7 January 2021

based on heuristic

inferred from DOI database lookup

Cross-validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403963

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytogenetic findings in 179 patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403963

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical characteristics of Japanese patients with primary myelodysplastic syndromes: a co-operative study based on 838 cases. Anemia Study Group of the Ministry of Health and Welfare

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403963

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403963

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2403963

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16193087

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46727255&oldid=1466082252"